Ivermectin: Moving Beyond Political Reflexes to Understand Its Mechanisms
by Laurent Glatz – for Athletic Carnivore
Ivermectin has become a loaded word. For some, it is reduced to a caricatured veterinary drug. For others, it is transformed into an almost miraculous symbol. In both cases, biology disappears. Yet a molecule should not be judged by the media noise it generates but by its mechanisms, doses, indications, limitations, and the quality of available evidence.
Ivermectin is first and foremost a recognized antiparasitic, long used in certain human and veterinary indications. This is its real foundation. But like many molecules, it is not always limited to its primary therapeutic label. Experimental studies also explore its effects on cellular pathways related to inflammation, energy signaling, certain immune responses, and mitochondrial mechanisms. This does not make it an established metabolic treatment. But it does mean the subject deserves more than slogans.
The problem with the public debate is that it has confused two questions. The first: does a molecule have interesting biological mechanisms in the lab or in certain models? The second: do these mechanisms translate in humans, at safe doses, for a specific indication, with a clear clinical benefit? There is a chasm between the two. Many activist discourses leap over this gap. Many institutional discourses sometimes refuse even to look at the first shore.
From a metabolic perspective, the pathways discussed around ivermectin notably involve AMPK, NF-kappa B, mitochondrial function, and certain inflammatory cascades. AMPK is often described as a cellular energy sensor. When activated, it pushes the cell toward better energy management, increases certain oxidation pathways, and limits storage signals. NF-kappa B, conversely, is a major player in inflammation. Any molecule capable of influencing these pathways deserves a serious mechanistic reading.
But understanding a mechanism does not mean prescribing a conclusion. Insulin, cortisol, inflammation, mitochondria, and immunity form a complex network. Modulation observed in a cell or animal model does not automatically prove practical utility in humans. The real body is not a Petri dish. It has pharmacokinetics, a liver, a microbiota, receptors, interactions, vulnerabilities, and toxicity thresholds.
This is precisely why we must be more rigorous, not less. Criticism of public discourse should not become an invitation to self-medicate. It should become a demand for precision. What dose? What indication? What level of evidence? What risk profile? Which markers monitored? What duration? What expected benefit? Without these questions, we leave physiology and enter belief.
The Athletic Carnivore approach focuses on the terrain. And the metabolic terrain is first worked on with the most powerful and fundamental levers: diet, sleep, stress, muscle mass, insulin, cortisol, inflammation, micronutrition, physical activity, light, recovery. A molecule can sometimes have medical interest in a defined context. But it does not replace a coherent terrain. A person seeking a molecule to compensate for an inflammatory diet, chronic hyperinsulinemia, poor sleep, or constant stress is not treating the root cause. They are adding a layer.
The real issue with ivermectin here is therefore not to glorify or condemn it. It is to show how modern debate destroys nuance. A molecule can be interesting on certain mechanisms and not validated for some promises. It can be useful in recognized indications and insufficiently proven in others. It can have real cellular effects without becoming a mainstream metabolic health solution.
Biology demands this precision. The media prefer camps. The body, however, responds neither to camps nor hashtags. It responds to doses, receptors, terrain, interactions, and clinical reality.
The final question is therefore not: should we believe or not believe in ivermectin? The real, more mature question is: are we still capable of analyzing a molecule without turning it into a totem, a scandal, or a magical shortcut?
#Ivermectin #Metabolism #Inflammation #AMPK #Mitochondria #Insulin #MetabolicHealth #Science #AthleticCarnivore
Discussion around this article
Ask a question or add your feedback directly below the article. The comment appears on the page and can be removed from the admin area if needed.
No comment published yet. Start the discussion.